Kopran Limited Reports Strong Q2 FY26-27 Financial and Operational Performance
Kopran Ltd · Investor Presentation · 03 Nov 2026, 8:39 pm
Kopran Limited Reports Strong Q2 FY26-27 Financial and Operational Performance Kopran Limited delivered robust growth in Q2 FY26-27, with consolidated revenue from operations rising 79.2% YoY to ₹21,126 lakhs. Operating EBITDA surged over sixfold YoY to ₹1,822 lakhs, expanding margins by 609 bps YoY to 8.62%. Net profit reached ₹439 lakhs, rebounding sharply from a net loss of ₹992 lakhs in Q2 FY25-26. For HY'26-27, revenue reached ₹36,526 lakhs with a net profit of ₹1,110 lakhs. API segment revenue totaled ₹12,321 lakhs, led by Carbapenem (₹8,249 lakhs), while formulations contributed ₹8,422 lakhs.
Original exchange filing (PDF)
More announcements from Kopran Ltd
- Reply to Exchange on Volume Movement Letter · 13 Nov 2026
- The Exchange has sought clarification from Kopran Ltd on November 13, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarvamangal Mercantile Company Ltd · 13 Nov 2026
- Kopran Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
- Unaudited Results for Q2 FY 2026-27 · 03 Nov 2026
- Unaudited results for second quarter ended September 30,2026 · 03 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 03 Nov 2026
- KOPRAN LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 03 Nov 2026
